Whitehawk Therapeutics, Inc.
|
AADI
|
Unlock Forecast
|
$83M
|
-1.0x
|
1.6x
|
Aardvark Therapeutics, Inc.
|
AARD
|
Unlock Forecast
|
$212M
|
x
|
1.6x
|
AbbVie Inc.
|
ABBV
|
Unlock Forecast
|
$0M
|
57.5x
|
0.0x
|
AbCellera Biologics Inc.
|
ABCL
|
Unlock Forecast
|
$1288M
|
-5.3x
|
1.3x
|
ABEONA THERAPEUTICS INC.
|
ABEO
|
Unlock Forecast
|
$339M
|
-2.5x
|
8.2x
|
ABBOTT LABORATORIES
|
ABT
|
Unlock Forecast
|
$230648M
|
16.5x
|
4.6x
|
Arbutus Biopharma Corp
|
ABUS
|
Unlock Forecast
|
$688M
|
-8.3x
|
8.3x
|
ABVC BIOPHARMA, INC.
|
ABVC
|
Unlock Forecast
|
$56M
|
-0.3x
|
10.3x
|
ACADIA PHARMACEUTICALS INC
|
ACAD
|
Unlock Forecast
|
$4340M
|
19.5x
|
5.3x
|
Adicet Bio, Inc.
|
ACET
|
Unlock Forecast
|
$65M
|
-0.4x
|
0.5x
|
Aclaris Therapeutics, Inc.
|
ACRS
|
Unlock Forecast
|
$221M
|
-4.5x
|
1.7x
|
Acrivon Therapeutics, Inc.
|
ACRV
|
Unlock Forecast
|
$51M
|
-2.8x
|
0.4x
|
ACTUATE THERAPEUTICS, INC.
|
ACTU
|
Unlock Forecast
|
$166M
|
x
|
-24.1x
|
Accustem Sciences Inc.
|
ACUT
|
Unlock Forecast
|
$30M
|
x
|
x
|
Acurx Pharmaceuticals, Inc.
|
ACXP
|
Unlock Forecast
|
$7M
|
-0.8x
|
1.9x
|
Adagene Inc.
|
ADAG
|
Unlock Forecast
|
$141M
|
x
|
3.7x
|
ADC Therapeutics SA
|
ADCT
|
Unlock Forecast
|
$358M
|
-9.2x
|
-1.3x
|
ADIAL PHARMACEUTICALS, INC.
|
ADIL
|
Unlock Forecast
|
$8M
|
-0.1x
|
1.5x
|
Aditxt, Inc.
|
ADTX
|
Unlock Forecast
|
$3M
|
0.0x
|
0.2x
|
AEON Biopharma, Inc.
|
AEON
|
Unlock Forecast
|
$9M
|
0.2x
|
-0.8x
|
AGIOS PHARMACEUTICALS, INC.
|
AGIO
|
Unlock Forecast
|
$2252M
|
3.5x
|
1.6x
|
Ainos, Inc.
|
AIMD
|
Unlock Forecast
|
$15M
|
-0.4x
|
1.3x
|
Ainos, Inc.
|
AIMDW
|
Unlock Forecast
|
$1M
|
x
|
0.0x
|
Akebia Therapeutics, Inc.
|
AKBA
|
Unlock Forecast
|
$1014M
|
-5.4x
|
41.2x
|
Akero Therapeutics, Inc.
|
AKRO
|
Unlock Forecast
|
$3903M
|
-8.7x
|
3.8x
|
Akari Therapeutics Plc
|
AKTX
|
Unlock Forecast
|
$60142M
|
-2.0x
|
2348.8x
|
Aldeyra Therapeutics, Inc.
|
ALDX
|
Unlock Forecast
|
$349M
|
-5.1x
|
6.3x
|
Alkermes plc.
|
ALKS
|
Unlock Forecast
|
$4842M
|
17.4x
|
3.2x
|
Allakos Inc.
|
ALLK
|
Unlock Forecast
|
$30M
|
-0.5x
|
0.5x
|
Allarity Therapeutics, Inc.
|
ALLR
|
Unlock Forecast
|
$14M
|
-0.2x
|
1.1x
|
ALUMIS INC.
|
ALMS
|
Unlock Forecast
|
$317M
|
x
|
0.7x
|
ALNYLAM PHARMACEUTICALS, INC.
|
ALNY
|
Unlock Forecast
|
$59513M
|
-224.3x
|
237.5x
|
Rein Therapeutics, Inc.
|
ALRN
|
Unlock Forecast
|
$43M
|
-1.4x
|
0.8x
|
Altimmune, Inc.
|
ALT
|
Unlock Forecast
|
$301M
|
-5.7x
|
1.9x
|
ALT5 Sigma Corp
|
ALTS
|
Unlock Forecast
|
$171M
|
-1.7x
|
6.6x
|
ALX ONCOLOGY HOLDINGS INC
|
ALXO
|
Unlock Forecast
|
$63M
|
-0.4x
|
1.0x
|
Alzamend Neuro, Inc.
|
ALZN
|
Unlock Forecast
|
$2M
|
-0.1x
|
0.5x
|
Amylyx Pharmaceuticals, Inc.
|
AMLX
|
Unlock Forecast
|
$743M
|
-1.5x
|
3.7x
|
Amphastar Pharmaceuticals, Inc.
|
AMPH
|
Unlock Forecast
|
$983M
|
13.9x
|
4.7x
|
AMARIN CORP PLC\UK
|
AMRN
|
Unlock Forecast
|
$6638M
|
-4.5x
|
14.3x
|
Amneal Pharmaceuticals, Inc.
|
AMRX
|
Unlock Forecast
|
$1292M
|
382.7x
|
0.0x
|
ANAPTYSBIO, INC
|
ANAB
|
Unlock Forecast
|
$811M
|
-2.5x
|
23.8x
|
Anebulo Pharmaceuticals, Inc.
|
ANEB
|
Unlock Forecast
|
$107M
|
-4.3x
|
7.9x
|
ANI PHARMACEUTICALS INC
|
ANIP
|
Unlock Forecast
|
$1923M
|
103.2x
|
4.4x
|
Anixa Biosciences Inc
|
ANIX
|
Unlock Forecast
|
$95M
|
-15.0x
|
4.3x
|
Annexon, Inc.
|
ANNX
|
Unlock Forecast
|
$328M
|
-4.1x
|
1.7x
|
Alto Neuroscience, Inc.
|
ANRO
|
Unlock Forecast
|
$106M
|
x
|
0.9x
|
AN2 Therapeutics, Inc.
|
ANTX
|
Unlock Forecast
|
$33M
|
-0.7x
|
0.5x
|
Annovis Bio, Inc.
|
ANVS
|
Unlock Forecast
|
$52M
|
-1.0x
|
2.2x
|
Apellis Pharmaceuticals, Inc.
|
APLS
|
Unlock Forecast
|
$3529M
|
-13.6x
|
22.6x
|
Applied Therapeutics, Inc.
|
APLT
|
Unlock Forecast
|
$67M
|
-0.7x
|
1.8x
|
Aprea Therapeutics, Inc.
|
APRE
|
Unlock Forecast
|
$9M
|
-1.2x
|
0.6x
|
Apimeds Pharmaceuticals US, Inc.
|
APUS
|
Unlock Forecast
|
$28M
|
x
|
2.8x
|
Aptevo Therapeutics Inc.
|
APVO
|
Unlock Forecast
|
$171M
|
-0.1x
|
38.6x
|
Aquestive Therapeutics, Inc.
|
AQST
|
Unlock Forecast
|
$395M
|
-10.7x
|
-6.9x
|
Arcturus Therapeutics Holdings Inc.
|
ARCT
|
Unlock Forecast
|
$503M
|
-7.0x
|
2.2x
|
ARDELYX, INC.
|
ARDX
|
Unlock Forecast
|
$1471M
|
-21.3x
|
10.5x
|
Arcutis Biotherapeutics, Inc.
|
ARQT
|
Unlock Forecast
|
$1749M
|
-6.6x
|
12.3x
|
ARTELO BIOSCIENCES, INC.
|
ARTL
|
Unlock Forecast
|
$7M
|
-0.7x
|
42.0x
|
ARVINAS, INC.
|
ARVN
|
Unlock Forecast
|
$536M
|
-4.8x
|
0.9x
|
ARROWHEAD PHARMACEUTICALS, INC.
|
ARWR
|
Unlock Forecast
|
$2932M
|
-4.7x
|
5.6x
|
Aspire Biopharma Holdings, Inc.
|
ASBP
|
Unlock Forecast
|
$27M
|
x
|
x
|
ASSEMBLY BIOSCIENCES, INC.
|
ASMB
|
Unlock Forecast
|
$207M
|
-1.5x
|
11.4x
|
Assertio Holdings, Inc.
|
ASRT
|
Unlock Forecast
|
$76M
|
-0.2x
|
0.8x
|
ATAI Life Sciences N.V.
|
ATAI
|
Unlock Forecast
|
$971M
|
-4.4x
|
6.8x
|
180 Life Sciences Corp.
|
ATNF
|
Unlock Forecast
|
$2M
|
-0.1x
|
0.6x
|
180 Life Sciences Corp.
|
ATNFW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Actinium Pharmaceuticals, Inc.
|
ATNM
|
Unlock Forecast
|
$42M
|
-4.1x
|
1.6x
|
ATOSSA THERAPEUTICS, INC.
|
ATOS
|
Unlock Forecast
|
$109M
|
-6.2x
|
1.7x
|
AVENUE THERAPEUTICS, INC.
|
ATXI
|
Unlock Forecast
|
$1M
|
-9.5x
|
0.3x
|
Astria Therapeutics, Inc.
|
ATXS
|
Unlock Forecast
|
$394M
|
-4.7x
|
1.5x
|
Aurinia Pharmaceuticals Inc.
|
AUPH
|
Unlock Forecast
|
$1720M
|
28.4x
|
5.1x
|
ArriVent BioPharma, Inc.
|
AVBP
|
Unlock Forecast
|
$754M
|
x
|
3.0x
|
AVADEL PHARMACEUTICALS PLC
|
AVDL
|
Unlock Forecast
|
$1507M
|
-10.2x
|
16.6x
|
Atea Pharmaceuticals, Inc.
|
AVIR
|
Unlock Forecast
|
$288M
|
-1.5x
|
0.7x
|
Jade Biosciences, Inc.
|
AVTE
|
Unlock Forecast
|
$2719M
|
-0.9x
|
36.2x
|
Avalo Therapeutics, Inc.
|
AVTX
|
Unlock Forecast
|
$68M
|
-0.1x
|
0.6x
|
Axsome Therapeutics, Inc.
|
AXSM
|
Unlock Forecast
|
$5500M
|
-19.9x
|
103.4x
|
AYTU BIOPHARMA, INC
|
AYTU
|
Unlock Forecast
|
$15M
|
-0.3x
|
0.4x
|
Azitra, Inc.
|
AZTR
|
Unlock Forecast
|
$4M
|
-0.2x
|
0.5x
|
BridgeBio Pharma, Inc.
|
BBIO
|
Unlock Forecast
|
$9333M
|
-11.6x
|
-5.4x
|
Bicara Therapeutics Inc.
|
BCAX
|
Unlock Forecast
|
$631M
|
x
|
1.5x
|
BriaCell Therapeutics Corp.
|
BCTX
|
Unlock Forecast
|
$44M
|
-1.7x
|
3.6x
|
BriaCell Therapeutics Corp.
|
BCTXW
|
Unlock Forecast
|
$4M
|
x
|
-2.5x
|
BICYCLE THERAPEUTICS PLC
|
BCYC
|
Unlock Forecast
|
$492M
|
-6.0x
|
0.7x
|
BeOne Medicines Ltd.
|
BEIGF
|
Unlock Forecast
|
$23196M
|
x
|
6.2x
|
BullFrog AI Holdings, Inc.
|
BFRG
|
Unlock Forecast
|
$12M
|
-2.9x
|
5.6x
|
BullFrog AI Holdings, Inc.
|
BFRGW
|
Unlock Forecast
|
$9M
|
x
|
2.4x
|
Biofrontera Inc.
|
BFRI
|
Unlock Forecast
|
$10M
|
-0.1x
|
17.9x
|
Biofrontera Inc.
|
BFRIW
|
Unlock Forecast
|
$1M
|
x
|
0.2x
|
BeiGene, Ltd.
|
BGNE
|
Unlock Forecast
|
$255876M
|
-454.6x
|
74.5x
|
Bausch Health Companies Inc.
|
BHC
|
Unlock Forecast
|
$-538M
|
-5.5x
|
-2.0x
|
Biohaven Ltd.
|
BHVN
|
Unlock Forecast
|
$1582M
|
-4.6x
|
11.8x
|
BioAge Labs, Inc.
|
BIOA
|
Unlock Forecast
|
$165M
|
x
|
0.6x
|
BIORA THERAPEUTICS, INC.
|
BIOR
|
Unlock Forecast
|
$1M
|
-0.1x
|
0.0x
|
BIOVIE INC.
|
BIVI
|
Unlock Forecast
|
$3M
|
-0.6x
|
0.2x
|
BELITE BIO, INC
|
BLTE
|
Unlock Forecast
|
$1877M
|
x
|
20.8x
|
Biomea Fusion, Inc.
|
BMEA
|
Unlock Forecast
|
$106M
|
-1.6x
|
3.9x
|
BIOMARIN PHARMACEUTICAL INC
|
BMRN
|
Unlock Forecast
|
$11519M
|
17.5x
|
1.9x
|
BRISTOL MYERS SQUIBB CO
|
BMY
|
Unlock Forecast
|
$98012M
|
19.4x
|
5.6x
|
BRISTOL MYERS SQUIBB CO
|
BMYMP
|
Unlock Forecast
|
$1655683M
|
327.9x
|
95.0x
|
Neuphoria Therapeutics Inc.
|
BNOX
|
Unlock Forecast
|
$13392M
|
x
|
784.5x
|
Benitec Biopharma Inc.
|
BNTC
|
Unlock Forecast
|
$265M
|
-0.6x
|
3.5x
|
Boundless Bio, Inc.
|
BOLD
|
Unlock Forecast
|
$26M
|
-15.1x
|
0.2x
|
Bolt Biotherapeutics, Inc.
|
BOLT
|
Unlock Forecast
|
$212M
|
-0.3x
|
4.5x
|
Blueprint Medicines Corp
|
BPMC
|
Unlock Forecast
|
$8361M
|
-32.3x
|
24.4x
|
BIO-PATH HOLDINGS, INC.
|
BPTH
|
Unlock Forecast
|
$1M
|
0.0x
|
-1.2x
|
Barinthus Biotherapeutics plc.
|
BRNS
|
Unlock Forecast
|
$60M
|
-0.6x
|
0.5x
|
BioXcel Therapeutics, Inc.
|
BTAI
|
Unlock Forecast
|
$12M
|
-0.1x
|
-0.1x
|
BeyondSpring Inc.
|
BYSI
|
Unlock Forecast
|
$41M
|
x
|
-3.1x
|
CalciMedica, Inc.
|
CALC
|
Unlock Forecast
|
$40M
|
0.4x
|
6.6x
|
Camp4 Therapeutics Corp
|
CAMP
|
Unlock Forecast
|
$31M
|
-0.1x
|
0.8x
|
Can-Fite BioPharma Ltd.
|
CANF
|
Unlock Forecast
|
$1202M
|
x
|
484.9x
|
CAPRICOR THERAPEUTICS, INC.
|
CAPR
|
Unlock Forecast
|
$327M
|
-14.1x
|
2.6x
|
Tvardi Therapeutics, Inc.
|
CARA
|
Unlock Forecast
|
$73M
|
-0.1x
|
-15.9x
|
Carisma Therapeutics Inc.
|
CARM
|
Unlock Forecast
|
$16M
|
-0.7x
|
114.0x
|
CASI Pharmaceuticals, Inc.
|
CASI
|
Unlock Forecast
|
$38M
|
-1.4x
|
20.3x
|
Perspective Therapeutics, Inc.
|
CATX
|
Unlock Forecast
|
$312M
|
-2.8x
|
1.1x
|
CRESCENT BIOPHARMA, INC.
|
CBIO
|
Unlock Forecast
|
$861M
|
-6.5x
|
255.1x
|
Avid Bioservices, Inc.
|
CDMO
|
Unlock Forecast
|
$799M
|
-6.6x
|
17.8x
|
CDT Equity Inc.
|
CDT
|
Unlock Forecast
|
$4M
|
-0.7x
|
1.1x
|
CONDUIT PHARMACEUTICALS INC.
|
CDTTW
|
Unlock Forecast
|
$2M
|
x
|
-0.2x
|
Celularity Inc
|
CELU
|
Unlock Forecast
|
$73M
|
-0.2x
|
8.2x
|
Celularity Inc
|
CELUW
|
Unlock Forecast
|
$1M
|
x
|
0.1x
|
Cingulate Inc.
|
CING
|
Unlock Forecast
|
$20M
|
-0.6x
|
3.7x
|
Cingulate Inc.
|
CINGW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Checkpoint Therapeutics, Inc.
|
CKPT
|
Unlock Forecast
|
$179M
|
-2.8x
|
-14.3x
|
Cell Source, Inc.
|
CLCS
|
Unlock Forecast
|
$18M
|
x
|
x
|
Clene Inc.
|
CLNN
|
Unlock Forecast
|
$54M
|
-7.3x
|
-6.9x
|
Clene Inc.
|
CLNNW
|
Unlock Forecast
|
$0M
|
x
|
-0.1x
|
Cellectar Biosciences, Inc.
|
CLRB
|
Unlock Forecast
|
$230M
|
-0.1x
|
27.9x
|
Clearside Biomedical, Inc.
|
CLSD
|
Unlock Forecast
|
$32M
|
-2.0x
|
-0.7x
|
Climb Bio, Inc.
|
CLYM
|
Unlock Forecast
|
$161M
|
-1.4x
|
0.9x
|
Chemomab Therapeutics Ltd.
|
CMMB
|
Unlock Forecast
|
$409M
|
10.9x
|
42.2x
|
COMPASS Pathways plc
|
CMPS
|
Unlock Forecast
|
$431M
|
0.0x
|
2.7x
|
CHIMERIX INC
|
CMRX
|
Unlock Forecast
|
$801M
|
-3.1x
|
6.6x
|
CNS Pharmaceuticals, Inc.
|
CNSP
|
Unlock Forecast
|
$3M
|
0.0x
|
0.3x
|
Centessa Pharmaceuticals plc
|
CNTA
|
Unlock Forecast
|
$2297M
|
-11.0x
|
6.7x
|
Connect Biopharma Holdings Ltd
|
CNTB
|
Unlock Forecast
|
$102M
|
x
|
1.4x
|
Context Therapeutics Inc.
|
CNTX
|
Unlock Forecast
|
$85M
|
-1.5x
|
1.0x
|
Cocrystal Pharma, Inc.
|
COCP
|
Unlock Forecast
|
$17M
|
-1.0x
|
1.0x
|
Cogent Biosciences, Inc.
|
COGT
|
Unlock Forecast
|
$1387M
|
-3.7x
|
9.0x
|
COLLEGIUM PHARMACEUTICAL, INC
|
COLL
|
Unlock Forecast
|
$1003M
|
12.0x
|
4.3x
|
CORCEPT THERAPEUTICS INC
|
CORT
|
Unlock Forecast
|
$8233M
|
50.6x
|
12.1x
|
Coya Therapeutics, Inc.
|
COYA
|
Unlock Forecast
|
$115M
|
-6.8x
|
4.1x
|
CHINA PHARMA HOLDINGS, INC.
|
CPHI
|
Unlock Forecast
|
$5M
|
-0.2x
|
0.7x
|
CUMBERLAND PHARMACEUTICALS INC
|
CPIX
|
Unlock Forecast
|
$50M
|
-4.5x
|
1.8x
|
CATALYST PHARMACEUTICALS, INC.
|
CPRX
|
Unlock Forecast
|
$2683M
|
12.9x
|
3.1x
|
GELESIS HOLDINGS, INC.
|
CPSR
|
Unlock Forecast
|
$1568M
|
-39.0x
|
18.0x
|
Corbus Pharmaceuticals Holdings, Inc.
|
CRBP
|
Unlock Forecast
|
$104M
|
-2.0x
|
0.8x
|
CorMedix Inc.
|
CRMD
|
Unlock Forecast
|
$1022M
|
20.0x
|
4.6x
|
Crinetics Pharmaceuticals, Inc.
|
CRNX
|
Unlock Forecast
|
$2910M
|
-15.9x
|
2.5x
|
CervoMed Inc.
|
CRVO
|
Unlock Forecast
|
$89M
|
-0.7x
|
2.7x
|
Corvus Pharmaceuticals, Inc.
|
CRVS
|
Unlock Forecast
|
$425M
|
-13.7x
|
5.3x
|
Catalent, Inc.
|
CTLT
|
Unlock Forecast
|
$11522M
|
-13.0x
|
3.3x
|
CytomX Therapeutics, Inc.
|
CTMX
|
Unlock Forecast
|
$231M
|
4.8x
|
1.9x
|
Contineum Therapeutics, Inc.
|
CTNM
|
Unlock Forecast
|
$34M
|
x
|
0.2x
|
CITIUS ONCOLOGY, INC.
|
CTOR
|
Unlock Forecast
|
$130M
|
3.9x
|
4.0x
|
Citius Pharmaceuticals, Inc.
|
CTXR
|
Unlock Forecast
|
$19M
|
-5.3x
|
0.3x
|
Cue Biopharma, Inc.
|
CUE
|
Unlock Forecast
|
$68M
|
-1.2x
|
10.3x
|
Cadrenal Therapeutics, Inc.
|
CVKD
|
Unlock Forecast
|
$26M
|
-11.1x
|
6.0x
|
CV Sciences, Inc.
|
CVSI
|
Unlock Forecast
|
$7M
|
x
|
4.1x
|
Cyclacel Pharmaceuticals, Inc.
|
CYCC
|
Unlock Forecast
|
$4658M
|
-0.1x
|
1521.1x
|
Cyclacel Pharmaceuticals, Inc.
|
CYCCP
|
Unlock Forecast
|
$1956M
|
-1.2x
|
638.9x
|
Cyclerion Therapeutics, Inc.
|
CYCN
|
Unlock Forecast
|
$11M
|
-5.2x
|
1.3x
|
CytoDyn Inc.
|
CYDY
|
Unlock Forecast
|
$375M
|
100.1x
|
x
|
Cryoport, Inc.
|
CYRX
|
Unlock Forecast
|
$439M
|
5.8x
|
0.9x
|
CYTOKINETICS INC
|
CYTK
|
Unlock Forecast
|
$4M
|
-9.4x
|
-13.9x
|
Dare Bioscience, Inc.
|
DARE
|
Unlock Forecast
|
$19M
|
2.9x
|
-2.3x
|
Day One Biopharmaceuticals, Inc.
|
DAWN
|
Unlock Forecast
|
$722M
|
-8.9x
|
1.6x
|
Denali Capital Acquisition Corp.
|
DECA
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Denali Capital Acquisition Corp.
|
DECAU
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Denali Capital Acquisition Corp.
|
DECAW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Journey Medical Corp
|
DERM
|
Unlock Forecast
|
$171M
|
24.1x
|
8.9x
|
DiaMedica Therapeutics Inc.
|
DMAC
|
Unlock Forecast
|
$263M
|
-4.2x
|
9.7x
|
Dianthus Therapeutics, Inc. /DE/
|
DNTH
|
Unlock Forecast
|
$656M
|
-3.2x
|
2.0x
|
Dermata Therapeutics, Inc.
|
DRMA
|
Unlock Forecast
|
$4M
|
-0.2x
|
0.8x
|
Dermata Therapeutics, Inc.
|
DRMAW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
DURECT CORP
|
DRRX
|
Unlock Forecast
|
$60M
|
-1.2x
|
17.1x
|
Design Therapeutics, Inc.
|
DSGN
|
Unlock Forecast
|
$226M
|
-7.6x
|
1.0x
|
DYNAVAX TECHNOLOGIES CORP
|
DVAX
|
Unlock Forecast
|
$1282M
|
88.2x
|
2.6x
|
Dogwood Therapeutics, Inc.
|
DWTX
|
Unlock Forecast
|
$116M
|
-2.9x
|
16.9x
|
Dyne Therapeutics, Inc.
|
DYN
|
Unlock Forecast
|
$1438M
|
-7.8x
|
2.5x
|
Emergent BioSolutions Inc.
|
EBS
|
Unlock Forecast
|
$523M
|
3.8x
|
1.0x
|
Edesa Biotech, Inc.
|
EDSA
|
Unlock Forecast
|
$8M
|
-1.3x
|
3.7x
|
EAGLE PHARMACEUTICALS, INC.
|
EGRX
|
Unlock Forecast
|
$42M
|
3.5x
|
0.2x
|
PMGC Holdings Inc.
|
ELAB
|
Unlock Forecast
|
$3M
|
-8.2x
|
0.4x
|
Elanco Animal Health Inc
|
ELAN
|
Unlock Forecast
|
$8948M
|
20.6x
|
1.3x
|
Eledon Pharmaceuticals, Inc.
|
ELDN
|
Unlock Forecast
|
$225M
|
-2.4x
|
2.0x
|
Elicio Therapeutics, Inc.
|
ELTX
|
Unlock Forecast
|
$149M
|
-1.9x
|
16.8x
|
Enliven Therapeutics, Inc.
|
ELVN
|
Unlock Forecast
|
$1228M
|
-13.3x
|
2.5x
|
Enlivex Therapeutics Ltd.
|
ENLV
|
Unlock Forecast
|
$22M
|
x
|
0.8x
|
Ensysce Biosciences, Inc.
|
ENSC
|
Unlock Forecast
|
$5M
|
-3.1x
|
1.7x
|
ENANTA PHARMACEUTICALS INC
|
ENTA
|
Unlock Forecast
|
$161M
|
-1.3x
|
1.7x
|
Entero Therapeutics, Inc.
|
ENTO
|
Unlock Forecast
|
$-85M
|
0.0x
|
0.3x
|
Enveric Biosciences, Inc.
|
ENVB
|
Unlock Forecast
|
$3M
|
-0.1x
|
0.8x
|
Evolus, Inc.
|
EOLS
|
Unlock Forecast
|
$593M
|
-13.1x
|
-89.8x
|
ESSA Pharma Inc.
|
EPIX
|
Unlock Forecast
|
$86M
|
-2.7x
|
0.8x
|
Equillium, Inc.
|
EQ
|
Unlock Forecast
|
$15M
|
-3.2x
|
1.4x
|
Erasca, Inc.
|
ERAS
|
Unlock Forecast
|
$454M
|
-3.1x
|
1.2x
|
Ernexa Therapeutics Inc.
|
ERNA
|
Unlock Forecast
|
$0M
|
-0.1x
|
-0.1x
|
Esperion Therapeutics, Inc.
|
ESPR
|
Unlock Forecast
|
$427M
|
-4.2x
|
-0.2x
|
89bio, Inc.
|
ETNB
|
Unlock Forecast
|
$1435M
|
-3.5x
|
2.8x
|
Eton Pharmaceuticals, Inc.
|
ETON
|
Unlock Forecast
|
$464M
|
-66.2x
|
19.4x
|
Evoke Pharma Inc
|
EVOK
|
Unlock Forecast
|
$7M
|
-1.8x
|
1.2x
|
Edgewise Therapeutics, Inc.
|
EWTX
|
Unlock Forecast
|
$1564M
|
-19.7x
|
2.7x
|
HYPERION DEFI, INC.
|
EYEN
|
Unlock Forecast
|
$46M
|
-0.1x
|
-4.7x
|
Fortress Biotech, Inc.
|
FBIO
|
Unlock Forecast
|
$7M
|
-0.2x
|
0.3x
|
Fortress Biotech, Inc.
|
FBIOP
|
Unlock Forecast
|
$26M
|
-0.6x
|
1.2x
|
FibroBiologics, Inc.
|
FBLG
|
Unlock Forecast
|
$22M
|
x
|
25.8x
|
Forte Biosciences, Inc.
|
FBRX
|
Unlock Forecast
|
$81M
|
-11.5x
|
2.1x
|
FIBROGEN INC
|
FGEN
|
Unlock Forecast
|
$37M
|
-0.2x
|
-3.6x
|
Foghorn Therapeutics Inc.
|
FHTX
|
Unlock Forecast
|
$347M
|
-3.3x
|
-5.5x
|
Flora Growth Corp.
|
FLGC
|
Unlock Forecast
|
$479M
|
-4.2x
|
119.0x
|
AMICUS THERAPEUTICS, INC.
|
FOLD
|
Unlock Forecast
|
$2344M
|
-8.5x
|
11.5x
|
Fulcrum Therapeutics, Inc.
|
FULC
|
Unlock Forecast
|
$430M
|
-36.1x
|
2.0x
|
GALECTIN THERAPEUTICS INC
|
GALT
|
Unlock Forecast
|
$259M
|
-2.4x
|
-1.6x
|
Gain Therapeutics, Inc.
|
GANX
|
Unlock Forecast
|
$47M
|
-1.4x
|
8.1x
|
Generation Bio Co.
|
GBIO
|
Unlock Forecast
|
$43M
|
-0.6x
|
0.8x
|
GERON CORP
|
GERN
|
Unlock Forecast
|
$968M
|
-11.9x
|
3.6x
|
Galmed Pharmaceuticals Ltd.
|
GLMD
|
Unlock Forecast
|
$M
|
x
|
x
|
Greenwich LifeSciences, Inc.
|
GLSI
|
Unlock Forecast
|
$164M
|
-17.2x
|
114.0x
|
Galecto, Inc.
|
GLTO
|
Unlock Forecast
|
$4M
|
-2.5x
|
0.4x
|
CRESCENT BIOPHARMA, INC.
|
GLYC
|
Unlock Forecast
|
$1013M
|
-0.5x
|
300.2x
|
GENELUX Corp
|
GNLX
|
Unlock Forecast
|
$126M
|
-2.8x
|
4.2x
|
Genprex, Inc.
|
GNPX
|
Unlock Forecast
|
$8M
|
-3.2x
|
2.0x
|
Gossamer Bio, Inc.
|
GOSS
|
Unlock Forecast
|
$386M
|
-3.2x
|
-61.8x
|
GeoVax Labs, Inc.
|
GOVX
|
Unlock Forecast
|
$12M
|
-0.8x
|
1.5x
|
GeoVax Labs, Inc.
|
GOVXW
|
Unlock Forecast
|
$1M
|
x
|
0.1x
|
Structure Therapeutics Inc.
|
GPCR
|
Unlock Forecast
|
$3387M
|
-44.0x
|
4.4x
|
Grace Therapeutics, Inc.
|
GRCE
|
Unlock Forecast
|
$52M
|
-3.9x
|
0.8x
|
GRI Bio, Inc.
|
GRI
|
Unlock Forecast
|
$4M
|
-0.1x
|
3.5x
|
Galera Therapeutics, Inc.
|
GRTX
|
Unlock Forecast
|
$2M
|
-0.3x
|
-0.1x
|
GT Biopharma, Inc.
|
GTBP
|
Unlock Forecast
|
$5M
|
-7.8x
|
-5.4x
|
GYRE THERAPEUTICS, INC.
|
GYRE
|
Unlock Forecast
|
$1172M
|
134.8x
|
12.7x
|
HUTCHMED (China) Ltd
|
HCM
|
Unlock Forecast
|
$14200M
|
x
|
11.6x
|
HCW Biologics Inc.
|
HCWB
|
Unlock Forecast
|
$0M
|
-0.4x
|
0.0x
|
Hepion Pharmaceuticals, Inc.
|
HEPA
|
Unlock Forecast
|
$1M
|
-0.1x
|
0.2x
|
Helix Acquisition Corp. II
|
HLXB
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
HUTCHMED (China) Ltd
|
HMDCF
|
Unlock Forecast
|
$2826M
|
x
|
2.3x
|
HOOKIPA Pharma Inc.
|
HOOK
|
Unlock Forecast
|
$11M
|
-1.0x
|
0.3x
|
Hoth Therapeutics, Inc.
|
HOTH
|
Unlock Forecast
|
$17M
|
-0.5x
|
1.8x
|
Werewolf Therapeutics, Inc.
|
HOWL
|
Unlock Forecast
|
$60M
|
-1.3x
|
1.4x
|
Harmony Biosciences Holdings, Inc.
|
HRMY
|
Unlock Forecast
|
$2214M
|
12.2x
|
2.9x
|
HARROW, INC.
|
HROW
|
Unlock Forecast
|
$1317M
|
-46.8x
|
23.3x
|
HARROW, INC.
|
HROWL
|
Unlock Forecast
|
$925M
|
-31.4x
|
16.4x
|
HARROW, INC.
|
HROWM
|
Unlock Forecast
|
$960M
|
-32.5x
|
17.0x
|
HERON THERAPEUTICS, INC. /DE/
|
HRTX
|
Unlock Forecast
|
$277M
|
-6.4x
|
-10.1x
|
TuHURA Biosciences, Inc./NV
|
HURA
|
Unlock Forecast
|
$114M
|
x
|
11.6x
|
HYPERION DEFI, INC.
|
HYPD
|
Unlock Forecast
|
$37M
|
x
|
-3.8x
|
iBio, Inc.
|
IBIO
|
Unlock Forecast
|
$8M
|
-0.4x
|
0.7x
|
IMPACT BIOMEDICAL INC.
|
IBO
|
Unlock Forecast
|
$10M
|
x
|
6.5x
|
IDEAYA Biosciences, Inc.
|
IDYA
|
Unlock Forecast
|
$1891M
|
-12.2x
|
1.9x
|
IGC Pharma, Inc.
|
IGC
|
Unlock Forecast
|
$31M
|
-4.6x
|
5.1x
|
IGM Biosciences, Inc.
|
IGMS
|
Unlock Forecast
|
$79M
|
-2.6x
|
0.8x
|
Immix Biopharma, Inc.
|
IMMX
|
Unlock Forecast
|
$83M
|
-2.8x
|
4.7x
|
Immunome Inc.
|
IMNM
|
Unlock Forecast
|
$896M
|
-2.4x
|
3.3x
|
Imunon, Inc.
|
IMNN
|
Unlock Forecast
|
$8M
|
-0.5x
|
17.8x
|
Enliven Therapeutics, Inc.
|
IMRA
|
Unlock Forecast
|
$2218M
|
-0.5x
|
4.5x
|
Immuneering Corp
|
IMRX
|
Unlock Forecast
|
$0M
|
-0.8x
|
0.0x
|
EOM Pharmaceutical Holdings, Inc.
|
IMUC
|
Unlock Forecast
|
$M
|
x
|
x
|
IMMUNIC, INC.
|
IMUX
|
Unlock Forecast
|
$111M
|
-0.8x
|
3.3x
|
Indaptus Therapeutics, Inc.
|
INDP
|
Unlock Forecast
|
$186M
|
-0.6x
|
66.4x
|
INDIVIOR PLC
|
INDV
|
Unlock Forecast
|
$3016M
|
x
|
x
|
InMed Pharmaceuticals Inc.
|
INM
|
Unlock Forecast
|
$3M
|
-51.8x
|
0.5x
|
INOVIO PHARMACEUTICALS, INC.
|
INO
|
Unlock Forecast
|
$76M
|
-0.6x
|
2.7x
|
INSMED Inc
|
INSM
|
Unlock Forecast
|
$27487M
|
-14.0x
|
22.0x
|
Innoviva, Inc.
|
INVA
|
Unlock Forecast
|
$1700M
|
44.0x
|
3.0x
|
Inozyme Pharma, Inc.
|
INZY
|
Unlock Forecast
|
$258M
|
-2.0x
|
8.1x
|
IO Biotech, Inc.
|
IOBT
|
Unlock Forecast
|
$112M
|
-0.7x
|
70.3x
|
IONIS PHARMACEUTICALS INC
|
IONS
|
Unlock Forecast
|
$6796M
|
-14.6x
|
10.8x
|
Opus Genetics, Inc.
|
IRD
|
Unlock Forecast
|
$69M
|
-2.0x
|
3.9x
|
Disc Medicine, Inc.
|
IRON
|
Unlock Forecast
|
$2094M
|
-18.4x
|
3.4x
|
IRONWOOD PHARMACEUTICALS INC
|
IRWD
|
Unlock Forecast
|
$206M
|
64.7x
|
-0.4x
|
International Stem Cell CORP
|
ISCO
|
Unlock Forecast
|
$0M
|
x
|
x
|
Intra-Cellular Therapies, Inc.
|
ITCI
|
Unlock Forecast
|
$14021M
|
-96.8x
|
12.2x
|
Iterum Therapeutics plc
|
ITRM
|
Unlock Forecast
|
$0M
|
-0.8x
|
0.0x
|
Incannex Healthcare Inc.
|
IXHL
|
Unlock Forecast
|
$11M
|
x
|
1.5x
|
Jaguar Health, Inc.
|
JAGX
|
Unlock Forecast
|
$0M
|
-0.2x
|
0.8x
|
Janux Therapeutics, Inc.
|
JANX
|
Unlock Forecast
|
$1503M
|
-63.7x
|
1.5x
|
Jazz Pharmaceuticals plc
|
JAZZ
|
Unlock Forecast
|
$7555M
|
14.3x
|
2.0x
|
Jade Biosciences, Inc.
|
JBIO
|
Unlock Forecast
|
$269M
|
x
|
1.3x
|
JOHNSON & JOHNSON
|
JNJ
|
Unlock Forecast
|
$432341M
|
19.1x
|
5.5x
|
JUPITER NEUROSCIENCES, INC.
|
JUNS
|
Unlock Forecast
|
$53M
|
x
|
39.5x
|
KALA BIO, Inc.
|
KALA
|
Unlock Forecast
|
$62M
|
-0.5x
|
6.5x
|
KalVista Pharmaceuticals, Inc.
|
KALV
|
Unlock Forecast
|
$800M
|
-2.6x
|
8.4x
|
Kairos Pharma, LTD.
|
KAPA
|
Unlock Forecast
|
$17M
|
x
|
2.4x
|
Kiniksa Pharmaceuticals International, plc
|
KNSA
|
Unlock Forecast
|
$0M
|
-64.7x
|
0.0x
|
KIORA PHARMACEUTICALS INC
|
KPRX
|
Unlock Forecast
|
$11M
|
-2.4x
|
0.5x
|
Karyopharm Therapeutics Inc.
|
KPTI
|
Unlock Forecast
|
$54M
|
-0.6x
|
-0.2x
|
Kronos Bio, Inc.
|
KRON
|
Unlock Forecast
|
$54M
|
-0.6x
|
0.7x
|
Keros Therapeutics, Inc.
|
KROS
|
Unlock Forecast
|
$558M
|
-13.3x
|
0.8x
|
Korro Bio, Inc.
|
KRRO
|
Unlock Forecast
|
$128M
|
-7.9x
|
1.6x
|
Pasithea Therapeutics Corp.
|
KTTA
|
Unlock Forecast
|
$5M
|
-73.5x
|
0.4x
|
Pasithea Therapeutics Corp.
|
KTTAW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Kura Oncology, Inc.
|
KURA
|
Unlock Forecast
|
$662M
|
-4.5x
|
2.2x
|
Kezar Life Sciences, Inc.
|
KZR
|
Unlock Forecast
|
$30M
|
-3.2x
|
0.3x
|
Longboard Pharmaceuticals, Inc.
|
LBPH
|
Unlock Forecast
|
$2342M
|
-27.9x
|
8.5x
|
Lexaria Bioscience Corp.
|
LEXX
|
Unlock Forecast
|
$14M
|
-29.3x
|
2.6x
|
Lexaria Bioscience Corp.
|
LEXXW
|
Unlock Forecast
|
$4M
|
x
|
0.5x
|
LIFECORE BIOMEDICAL, INC. \DE\
|
LFCR
|
Unlock Forecast
|
$298M
|
-5.1x
|
133.6x
|
Lifevantage Corp
|
LFVN
|
Unlock Forecast
|
$163M
|
54.8x
|
4.8x
|
LIGAND PHARMACEUTICALS INC
|
LGND
|
Unlock Forecast
|
$2684M
|
65.6x
|
3.4x
|
Longeveron Inc.
|
LGVN
|
Unlock Forecast
|
$0M
|
-0.5x
|
0.0x
|
LianBio
|
LIANY
|
Unlock Forecast
|
$7M
|
x
|
0.0x
|
LFTD PARTNERS INC.
|
LIFD
|
Unlock Forecast
|
$4M
|
x
|
0.1x
|
LIPELLA PHARMACEUTICALS INC.
|
LIPO
|
Unlock Forecast
|
$3M
|
-3.3x
|
1.0x
|
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
|
LIXT
|
Unlock Forecast
|
$11M
|
-0.9x
|
9.4x
|
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
|
LIXTW
|
Unlock Forecast
|
$0M
|
x
|
0.4x
|
ELI LILLY & Co
|
LLY
|
Unlock Forecast
|
$628546M
|
45.6x
|
34.4x
|
Lipocine Inc.
|
LPCN
|
Unlock Forecast
|
$17M
|
-2.6x
|
0.9x
|
LEAP THERAPEUTICS, INC.
|
LPTX
|
Unlock Forecast
|
$14M
|
-1.1x
|
0.7x
|
Liquidia Corp
|
LQDA
|
Unlock Forecast
|
$2305M
|
-7.2x
|
151.7x
|
Larimar Therapeutics, Inc.
|
LRMR
|
Unlock Forecast
|
$206M
|
-0.8x
|
1.4x
|
LISATA THERAPEUTICS, INC.
|
LSTA
|
Unlock Forecast
|
$22M
|
-1.0x
|
1.0x
|
Lantern Pharma Inc.
|
LTRN
|
Unlock Forecast
|
$49M
|
-2.4x
|
3.9x
|
LUMOS PHARMA, INC.
|
LUMO
|
Unlock Forecast
|
$38M
|
-1.0x
|
7.6x
|
LAVA Therapeutics NV
|
LVTX
|
Unlock Forecast
|
$41M
|
x
|
2.1x
|
LEXICON PHARMACEUTICALS, INC.
|
LXRX
|
Unlock Forecast
|
$0M
|
-1.2x
|
0.0x
|
Lyell Immunopharma, Inc.
|
LYEL
|
Unlock Forecast
|
$160M
|
-1.1x
|
0.5x
|
MAIA Biotechnology, Inc.
|
MAIA
|
Unlock Forecast
|
$50M
|
-1.4x
|
13.0x
|
MUSTANG BIO, INC.
|
MBIO
|
Unlock Forecast
|
$6M
|
-0.1x
|
2.0x
|
Moleculin Biotech, Inc.
|
MBRX
|
Unlock Forecast
|
$11M
|
-2.3x
|
269.8x
|
MBX Biosciences, Inc.
|
MBX
|
Unlock Forecast
|
$464M
|
x
|
2.1x
|
Seres Therapeutics, Inc.
|
MCRB
|
Unlock Forecast
|
$123M
|
-1.0x
|
2.4x
|
Medicus Pharma Ltd.
|
MDCX
|
Unlock Forecast
|
$35M
|
x
|
x
|
Medicus Pharma Ltd.
|
MDCXW
|
Unlock Forecast
|
$40M
|
x
|
x
|
MADRIGAL PHARMACEUTICALS, INC.
|
MDGL
|
Unlock Forecast
|
$9215M
|
-5.7x
|
13.2x
|
23andMe Holding Co.
|
ME
|
Unlock Forecast
|
$0M
|
-4.6x
|
0.0x
|
MEI Pharma, Inc.
|
MEIP
|
Unlock Forecast
|
$39M
|
16.6x
|
2.0x
|
MACROGENICS INC
|
MGNX
|
Unlock Forecast
|
$107M
|
-2.1x
|
2.3x
|
MIRA PHARMACEUTICALS, INC.
|
MIRA
|
Unlock Forecast
|
$25M
|
-1.6x
|
43.6x
|
Mirum Pharmaceuticals, Inc.
|
MIRM
|
Unlock Forecast
|
$3580M
|
-20.0x
|
14.0x
|
Milestone Pharmaceuticals Inc.
|
MIST
|
Unlock Forecast
|
$91M
|
-2.0x
|
4.2x
|
MoonLake Immunotherapeutics
|
MLTX
|
Unlock Forecast
|
$3543M
|
-50.8x
|
10.0x
|
Mineralys Therapeutics, Inc.
|
MLYS
|
Unlock Forecast
|
$978M
|
-4.5x
|
3.1x
|
MANNKIND CORP
|
MNKD
|
Unlock Forecast
|
$1234M
|
37.6x
|
-20.2x
|
MEDICINOVA INC
|
MNOV
|
Unlock Forecast
|
$60M
|
-7.1x
|
1.2x
|
Monopar Therapeutics
|
MNPR
|
Unlock Forecast
|
$289M
|
-3.0x
|
5.4x
|
Mereo BioPharma Group plc
|
MREO
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Merck & Co., Inc.
|
MRK
|
Unlock Forecast
|
$0M
|
17.5x
|
0.0x
|
Marker Therapeutics, Inc.
|
MRKR
|
Unlock Forecast
|
$16M
|
-0.6x
|
1.5x
|
MARINUS PHARMACEUTICALS, INC.
|
MRNS
|
Unlock Forecast
|
$30M
|
-0.1x
|
-0.5x
|
Mersana Therapeutics, Inc.
|
MRSN
|
Unlock Forecast
|
$39M
|
-3.4x
|
-1.4x
|
Merus N.V.
|
MRUS
|
Unlock Forecast
|
$5100M
|
-13.5x
|
6.1x
|
MARAVAI LIFESCIENCES HOLDINGS, INC.
|
MRVI
|
Unlock Forecast
|
$608M
|
-5.6x
|
2.3x
|
Molecular Templates, Inc.
|
MTEM
|
Unlock Forecast
|
$3M
|
1.7x
|
0.4x
|
Matinas BioPharma Holdings, Inc.
|
MTNB
|
Unlock Forecast
|
$3M
|
-1.7x
|
0.2x
|
Metsera, Inc.
|
MTSR
|
Unlock Forecast
|
$3460M
|
x
|
7.7x
|
MetaVia Inc.
|
MTVA
|
Unlock Forecast
|
$16M
|
-0.5x
|
1.6x
|
Mural Oncology plc
|
MURA
|
Unlock Forecast
|
$36M
|
x
|
0.6x
|
NewAmsterdam Pharma Co N.V.
|
NAMS
|
Unlock Forecast
|
$2885M
|
x
|
3.7x
|
NewAmsterdam Pharma Co N.V.
|
NAMSW
|
Unlock Forecast
|
$1629M
|
x
|
2.1x
|
NATURES SUNSHINE PRODUCTS INC
|
NATR
|
Unlock Forecast
|
$321M
|
22.7x
|
2.0x
|
NovaBay Pharmaceuticals, Inc.
|
NBY
|
Unlock Forecast
|
$4M
|
-1.8x
|
0.6x
|
Endo LP
|
NDOI
|
Unlock Forecast
|
$1798M
|
x
|
1.6x
|
Minerva Neurosciences, Inc.
|
NERV
|
Unlock Forecast
|
$14M
|
-0.8x
|
-0.5x
|
Neuphoria Therapeutics Inc.
|
NEUP
|
Unlock Forecast
|
$13M
|
x
|
0.5x
|
Neurogene Inc.
|
NGNE
|
Unlock Forecast
|
$420M
|
-7.3x
|
1.5x
|
NIKA PHARMACEUTICALS, INC
|
NIKA
|
Unlock Forecast
|
$973M
|
x
|
x
|
NEKTAR THERAPEUTICS
|
NKTR
|
Unlock Forecast
|
$380M
|
-1.2x
|
337.9x
|
Nkarta, Inc.
|
NKTX
|
Unlock Forecast
|
$175M
|
-1.3x
|
0.5x
|
NLS Pharmaceutics Ltd.
|
NLSP
|
Unlock Forecast
|
$18M
|
x
|
33.8x
|
NLS Pharmaceutics Ltd.
|
NLSPW
|
Unlock Forecast
|
$0M
|
x
|
0.2x
|
NANOVIRICIDES, INC.
|
NNVC
|
Unlock Forecast
|
$28M
|
-2.1x
|
2.8x
|
MetaVia Inc.
|
NRBO
|
Unlock Forecast
|
$20M
|
-0.5x
|
1.5x
|
Nurix Therapeutics, Inc.
|
NRIX
|
Unlock Forecast
|
$849M
|
-7.4x
|
1.9x
|
NeuroSense Therapeutics Ltd.
|
NRSN
|
Unlock Forecast
|
$30M
|
x
|
x
|
NRX Pharmaceuticals, Inc.
|
NRXP
|
Unlock Forecast
|
$52M
|
-0.6x
|
-2.1x
|
NRX Pharmaceuticals, Inc.
|
NRXPW
|
Unlock Forecast
|
$1M
|
x
|
0.0x
|
NEONC TECHNOLOGIES HOLDINGS, INC.
|
NTHI
|
Unlock Forecast
|
$111M
|
x
|
x
|
Nuvation Bio Inc.
|
NUVB
|
Unlock Forecast
|
$783M
|
-1.2x
|
1.9x
|
Nuvalent, Inc.
|
NUVL
|
Unlock Forecast
|
$5389M
|
-30.9x
|
5.7x
|
Nuvectis Pharma, Inc.
|
NVCT
|
Unlock Forecast
|
$164M
|
-3.9x
|
9.7x
|
NORTHWEST BIOTHERAPEUTICS INC
|
NWBO
|
Unlock Forecast
|
$315M
|
x
|
x
|
NEXIEN BIOPHARMA, INC.
|
NXEN
|
Unlock Forecast
|
$0M
|
x
|
x
|
NextCure, Inc.
|
NXTC
|
Unlock Forecast
|
$140M
|
-0.5x
|
2.5x
|
Ocean Biomedical, Inc.
|
OCEA
|
Unlock Forecast
|
$1M
|
-0.3x
|
0.0x
|
Ocean Biomedical, Inc.
|
OCEAW
|
Unlock Forecast
|
$1M
|
x
|
0.0x
|
OCULAR THERAPEUTIX, INC
|
OCUL
|
Unlock Forecast
|
$2127M
|
-8.2x
|
7.0x
|
ORAGENICS INC
|
OGEN
|
Unlock Forecast
|
$126M
|
-0.1x
|
917.2x
|
Organon & Co.
|
OGN
|
Unlock Forecast
|
$2457M
|
3.5x
|
3.4x
|
OnKure Therapeutics, Inc.
|
OKUR
|
Unlock Forecast
|
$38M
|
-6.9x
|
0.5x
|
Olema Pharmaceuticals, Inc.
|
OLMA
|
Unlock Forecast
|
$492M
|
-4.0x
|
1.4x
|
OMEROS CORP
|
OMER
|
Unlock Forecast
|
$197M
|
-4.2x
|
-0.9x
|
BeOne Medicines Ltd.
|
ONC
|
Unlock Forecast
|
$456620M
|
x
|
121.1x
|
Onconetix, Inc.
|
ONCO
|
Unlock Forecast
|
$153M
|
-0.3x
|
17.9x
|
Oncternal Therapeutics, Inc.
|
ONCT
|
Unlock Forecast
|
$2M
|
0.0x
|
0.2x
|
OPKO HEALTH, INC.
|
OPK
|
Unlock Forecast
|
$473M
|
-3.5x
|
0.3x
|
OptiNose, Inc.
|
OPTN
|
Unlock Forecast
|
$97M
|
-1.5x
|
-1.6x
|
Organogenesis Holdings Inc.
|
ORGO
|
Unlock Forecast
|
$554M
|
-32.9x
|
2.3x
|
Oric Pharmaceuticals, Inc.
|
ORIC
|
Unlock Forecast
|
$839M
|
-4.2x
|
2.6x
|
Oruka Therapeutics, Inc.
|
ORKA
|
Unlock Forecast
|
$544M
|
x
|
1.5x
|
ORAMED PHARMACEUTICALS INC.
|
ORMP
|
Unlock Forecast
|
$87M
|
21.9x
|
0.6x
|
OS Therapies Inc
|
OSTX
|
Unlock Forecast
|
$100M
|
x
|
20.3x
|
Oncotelic Therapeutics, Inc.
|
OTLC
|
Unlock Forecast
|
$18M
|
x
|
2.2x
|
Ovid Therapeutics Inc.
|
OVID
|
Unlock Forecast
|
$81M
|
-2.6x
|
1.5x
|
One World Products, Inc.
|
OWPC
|
Unlock Forecast
|
$1M
|
x
|
x
|
PHIBRO ANIMAL HEALTH CORP
|
PAHC
|
Unlock Forecast
|
$1320M
|
41.5x
|
5.0x
|
Prestige Consumer Healthcare Inc.
|
PBH
|
Unlock Forecast
|
$3324M
|
15.6x
|
1.8x
|
PUMA BIOTECHNOLOGY, INC.
|
PBYI
|
Unlock Forecast
|
$263M
|
5.4x
|
2.5x
|
Pacira BioSciences, Inc.
|
PCRX
|
Unlock Forecast
|
$1032M
|
-7534.1x
|
1.3x
|
Processa Pharmaceuticals, Inc.
|
PCSA
|
Unlock Forecast
|
$2M
|
-0.5x
|
0.5x
|
PDS Biotechnology Corp
|
PDSB
|
Unlock Forecast
|
$55M
|
-1.7x
|
3.5x
|
PepGen Inc.
|
PEPG
|
Unlock Forecast
|
$43M
|
-1.6x
|
0.6x
|
PFIZER INC
|
PFE
|
Unlock Forecast
|
$148251M
|
13.8x
|
1.7x
|
PRECIGEN, INC.
|
PGEN
|
Unlock Forecast
|
$520M
|
-1.4x
|
-37.0x
|
Phathom Pharmaceuticals, Inc.
|
PHAT
|
Unlock Forecast
|
$855M
|
-1.6x
|
-1.6x
|
Phio Pharmaceuticals Corp.
|
PHIO
|
Unlock Forecast
|
$12M
|
-0.8x
|
1.0x
|
PALVELLA THERAPEUTICS, INC.
|
PIRS
|
Unlock Forecast
|
$0M
|
-5.1x
|
0.0x
|
PLIANT THERAPEUTICS, INC.
|
PLRX
|
Unlock Forecast
|
$88M
|
-4.5x
|
0.3x
|
ProMIS Neurosciences Inc.
|
PMN
|
Unlock Forecast
|
$19M
|
-2.1x
|
2.1x
|
PMV Pharmaceuticals, Inc.
|
PMVP
|
Unlock Forecast
|
$78M
|
-1.6x
|
0.6x
|
Propanc Biopharma, Inc.
|
PPCB
|
Unlock Forecast
|
$39M
|
x
|
2.2x
|
Praxis Precision Medicines, Inc.
|
PRAX
|
Unlock Forecast
|
$1037M
|
-4.0x
|
2.6x
|
PAINREFORM LTD.
|
PRFX
|
Unlock Forecast
|
$7M
|
x
|
x
|
PERRIGO Co plc
|
PRGO
|
Unlock Forecast
|
$3706M
|
-27.6x
|
0.9x
|
Prelude Therapeutics Inc
|
PRLD
|
Unlock Forecast
|
$0M
|
-0.5x
|
0.0x
|
ProPhase Labs, Inc.
|
PRPH
|
Unlock Forecast
|
$15M
|
-0.5x
|
1.0x
|
PROTHENA CORP PUBLIC LTD CO
|
PRTA
|
Unlock Forecast
|
$348M
|
-12.4x
|
0.8x
|
PTC THERAPEUTICS, INC.
|
PTCT
|
Unlock Forecast
|
$4374M
|
7.0x
|
-20.3x
|
Protagonist Therapeutics, Inc
|
PTGX
|
Unlock Forecast
|
$3635M
|
69.9x
|
5.4x
|
Protagenic Therapeutics, Inc.\new
|
PTIX
|
Unlock Forecast
|
$2M
|
-2.8x
|
-22.8x
|
PALATIN TECHNOLOGIES INC
|
PTN
|
Unlock Forecast
|
$4M
|
-11.9x
|
-0.6x
|
Petros Pharmaceuticals, Inc.
|
PTPI
|
Unlock Forecast
|
$1M
|
-0.1x
|
-0.1x
|
Pulmatrix, Inc.
|
PULM
|
Unlock Forecast
|
$23M
|
-1.8x
|
3.2x
|
PROVECTUS BIOPHARMACEUTICALS, INC.
|
PVCT
|
Unlock Forecast
|
$34M
|
x
|
x
|
PALVELLA THERAPEUTICS, INC.
|
PVLA
|
Unlock Forecast
|
$327M
|
x
|
5.9x
|
Aspire Biopharma Holdings, Inc.
|
PWUP
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Aspire Biopharma Holdings, Inc.
|
PWUPU
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Aspire Biopharma Holdings, Inc.
|
PWUPW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Pyxis Oncology, Inc.
|
PYXS
|
Unlock Forecast
|
$70M
|
-1.3x
|
0.7x
|
Qualigen Therapeutics, Inc.
|
QLGN
|
Unlock Forecast
|
$5M
|
-1.3x
|
-1.1x
|
Quoin Pharmaceuticals, Ltd.
|
QNRX
|
Unlock Forecast
|
$148M
|
x
|
58.1x
|
Q32 Bio Inc.
|
QTTB
|
Unlock Forecast
|
$27M
|
-0.7x
|
-6.7x
|
uniQure N.V.
|
QURE
|
Unlock Forecast
|
$821M
|
-2.8x
|
24.4x
|
Rani Therapeutics Holdings, Inc.
|
RANI
|
Unlock Forecast
|
$0M
|
-1.3x
|
0.0x
|
Rapport Therapeutics, Inc.
|
RAPP
|
Unlock Forecast
|
$539M
|
x
|
2.1x
|
RAPT Therapeutics, Inc.
|
RAPT
|
Unlock Forecast
|
$155M
|
-0.4x
|
0.9x
|
Ultragenyx Pharmaceutical Inc.
|
RARE
|
Unlock Forecast
|
$2487M
|
-7.0x
|
17.2x
|
ROCKET PHARMACEUTICALS, INC.
|
RCKT
|
Unlock Forecast
|
$328M
|
-4.8x
|
0.8x
|
ROCKET PHARMACEUTICALS, INC.
|
RCKTW
|
Unlock Forecast
|
$6M
|
x
|
0.0x
|
Arcus Biosciences, Inc.
|
RCUS
|
Unlock Forecast
|
$969M
|
-5.5x
|
1.8x
|
REGENERON PHARMACEUTICALS, INC.
|
REGN
|
Unlock Forecast
|
$64784M
|
14.5x
|
2.2x
|
RENOVARO INC.
|
RENB
|
Unlock Forecast
|
$55M
|
-0.9x
|
0.6x
|
REVELATION BIOSCIENCES, INC.
|
REVB
|
Unlock Forecast
|
$4M
|
-0.1x
|
1.1x
|
REVELATION BIOSCIENCES, INC.
|
REVBW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Rafael Holdings, Inc.
|
RFL
|
Unlock Forecast
|
$41M
|
-0.9x
|
0.5x
|
Regulus Therapeutics Inc.
|
RGLS
|
Unlock Forecast
|
$565M
|
3.2x
|
8.2x
|
RIGEL PHARMACEUTICALS INC
|
RIGL
|
Unlock Forecast
|
$754M
|
7.7x
|
9.2x
|
RELMADA THERAPEUTICS, INC.
|
RLMD
|
Unlock Forecast
|
$19M
|
-0.1x
|
0.9x
|
Rallybio Corp
|
RLYB
|
Unlock Forecast
|
$28M
|
-0.7x
|
0.6x
|
ROCKWELL MEDICAL, INC.
|
RMTI
|
Unlock Forecast
|
$39M
|
-17.1x
|
1.3x
|
Avidity Biosciences, Inc.
|
RNA
|
Unlock Forecast
|
$5999M
|
-12.2x
|
5.0x
|
Cartesian Therapeutics, Inc.
|
RNAC
|
Unlock Forecast
|
$292M
|
-2.1x
|
-14.1x
|
Transcode Therapeutics, Inc.
|
RNAZ
|
Unlock Forecast
|
$9M
|
-0.2x
|
1.4x
|
Rein Therapeutics, Inc.
|
RNTX
|
Unlock Forecast
|
$31M
|
x
|
0.6x
|
RenovoRx, Inc.
|
RNXT
|
Unlock Forecast
|
$33M
|
-3.4x
|
3.1x
|
Roivant Sciences Ltd.
|
ROIV
|
Unlock Forecast
|
$9012M
|
1.8x
|
2.1x
|
Royalty Pharma plc
|
RPRX
|
Unlock Forecast
|
$31000M
|
30.4x
|
4.9x
|
Repare Therapeutics Inc.
|
RPTX
|
Unlock Forecast
|
$68M
|
-2.1x
|
0.6x
|
ReShape Lifesciences Inc.
|
RSLS
|
Unlock Forecast
|
$2M
|
-3.7x
|
1.9x
|
Rapid Therapeutic Science Laboratories, Inc.
|
RTSL
|
Unlock Forecast
|
$0M
|
0.5x
|
x
|
Revance Therapeutics, Inc.
|
RVNC
|
Unlock Forecast
|
$383M
|
-1.0x
|
-2.4x
|
REVIVA PHARMACEUTICALS HOLDINGS, INC.
|
RVPH
|
Unlock Forecast
|
$37M
|
-4.1x
|
-4.3x
|
REVIVA PHARMACEUTICALS HOLDINGS, INC.
|
RVPHW
|
Unlock Forecast
|
$5M
|
x
|
-0.5x
|
RHYTHM PHARMACEUTICALS, INC.
|
RYTM
|
Unlock Forecast
|
$-71726M
|
-20.3x
|
2603.1x
|
Rezolute, Inc.
|
RZLT
|
Unlock Forecast
|
$489M
|
-3.9x
|
5.9x
|
Sage Therapeutics, Inc.
|
SAGE
|
Unlock Forecast
|
$544M
|
-1.2x
|
1.5x
|
CASSAVA SCIENCES INC
|
SAVA
|
Unlock Forecast
|
$106M
|
-1.9x
|
1.2x
|
Sunshine Biopharma Inc.
|
SBFM
|
Unlock Forecast
|
$4M
|
-0.6x
|
0.2x
|
Sunshine Biopharma Inc.
|
SBFMW
|
Unlock Forecast
|
$1M
|
x
|
0.0x
|
Scienture Holdings, Inc.
|
SCNX
|
Unlock Forecast
|
$17M
|
2.9x
|
0.2x
|
scPharmaceuticals Inc.
|
SCPH
|
Unlock Forecast
|
$297M
|
-2.0x
|
-50.9x
|
Scorpius Holdings, Inc.
|
SCPX
|
Unlock Forecast
|
$1M
|
0.0x
|
0.0x
|
SCYNEXIS INC
|
SCYX
|
Unlock Forecast
|
$40M
|
-2.4x
|
0.9x
|
Schrodinger, Inc.
|
SDGR
|
Unlock Forecast
|
$1488M
|
-7.8x
|
4.3x
|
Septerna, Inc.
|
SEPN
|
Unlock Forecast
|
$534M
|
x
|
1.4x
|
Serina Therapeutics, Inc.
|
SER
|
Unlock Forecast
|
$52M
|
22.6x
|
29.1x
|
Sagimet Biosciences Inc.
|
SGMT
|
Unlock Forecast
|
$281M
|
x
|
2.0x
|
Shuttle Pharmaceuticals Holdings, Inc.
|
SHPH
|
Unlock Forecast
|
$1M
|
-0.5x
|
0.4x
|
SIGA TECHNOLOGIES INC
|
SIGA
|
Unlock Forecast
|
$472M
|
8.0x
|
2.2x
|
Silo Pharma, Inc.
|
SILO
|
Unlock Forecast
|
$3M
|
-1.4x
|
0.7x
|
Sionna Therapeutics, Inc.
|
SION
|
Unlock Forecast
|
$1076M
|
x
|
3.2x
|
Skye Bioscience, Inc.
|
SKYE
|
Unlock Forecast
|
$130M
|
-0.7x
|
3.0x
|
Sol-Gel Technologies Ltd.
|
SLGL
|
Unlock Forecast
|
$63M
|
x
|
2.0x
|
Silence Therapeutics plc
|
SLN
|
Unlock Forecast
|
$750M
|
x
|
8.0x
|
Silence Therapeutics plc
|
SLNCF
|
Unlock Forecast
|
$239M
|
x
|
2.5x
|
ACELYRIN, Inc.
|
SLRN
|
Unlock Forecast
|
$229M
|
-23.5x
|
0.6x
|
Salarius Pharmaceuticals, Inc.
|
SLRX
|
Unlock Forecast
|
$1M
|
-0.5x
|
21.2x
|
SELLAS Life Sciences Group, Inc.
|
SLS
|
Unlock Forecast
|
$177M
|
-1.0x
|
6.4x
|
Summit Therapeutics Inc.
|
SMMT
|
Unlock Forecast
|
$19562M
|
104.1x
|
56.8x
|
Syndax Pharmaceuticals Inc
|
SNDX
|
Unlock Forecast
|
$1401M
|
-4.1x
|
8.9x
|
SOLIGENIX, INC.
|
SNGX
|
Unlock Forecast
|
$4M
|
-1.8x
|
1.2x
|
Sibannac, Inc.
|
SNNC
|
Unlock Forecast
|
$0M
|
x
|
x
|
TAO Synergies Inc.
|
SNPX
|
Unlock Forecast
|
$13M
|
4.2x
|
2.5x
|
Sensei Biotherapeutics, Inc.
|
SNSE
|
Unlock Forecast
|
$10M
|
-0.4x
|
0.4x
|
Sonnet BioTherapeutics Holdings, Inc.
|
SONN
|
Unlock Forecast
|
$20M
|
-1.6x
|
29.5x
|
SPRUCE BIOSCIENCES, INC.
|
SPRB
|
Unlock Forecast
|
$3M
|
-0.4x
|
0.1x
|
Spero Therapeutics, Inc.
|
SPRO
|
Unlock Forecast
|
$105M
|
-17.8x
|
3.2x
|
ARS Pharmaceuticals, Inc.
|
SPRY
|
Unlock Forecast
|
$1760M
|
-23.5x
|
7.7x
|
Sarepta Therapeutics, Inc.
|
SRPT
|
Unlock Forecast
|
$1976M
|
162.5x
|
1.5x
|
Stoke Therapeutics, Inc.
|
STOK
|
Unlock Forecast
|
$1175M
|
22.4x
|
3.5x
|
Shattuck Labs, Inc.
|
STTK
|
Unlock Forecast
|
$36M
|
-0.7x
|
0.5x
|
SUPERNUS PHARMACEUTICALS, INC.
|
SUPN
|
Unlock Forecast
|
$2544M
|
39.5x
|
2.4x
|
Savara Inc
|
SVRA
|
Unlock Forecast
|
$462M
|
-8.2x
|
2.3x
|
60 DEGREES PHARMACEUTICALS, INC.
|
SXTP
|
Unlock Forecast
|
$2M
|
-0.6x
|
0.8x
|
60 DEGREES PHARMACEUTICALS, INC.
|
SXTPW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
SYNLOGIC, INC.
|
SYBX
|
Unlock Forecast
|
$20M
|
-0.2x
|
1.5x
|
Spyre Therapeutics, Inc.
|
SYRE
|
Unlock Forecast
|
$1019M
|
-0.7x
|
2.1x
|
Syros Pharmaceuticals, Inc.
|
SYRS
|
Unlock Forecast
|
$5M
|
-0.1x
|
-0.4x
|
TAO Synergies Inc.
|
TAOX
|
Unlock Forecast
|
$20M
|
x
|
1.2x
|
Theravance Biopharma, Inc.
|
TBPH
|
Unlock Forecast
|
$695M
|
53.3x
|
3.1x
|
Alaunos Therapeutics, Inc.
|
TCRT
|
Unlock Forecast
|
$4M
|
-1.0x
|
1.0x
|
Telomir Pharmaceuticals, Inc.
|
TELO
|
Unlock Forecast
|
$45M
|
x
|
92.6x
|
TENAX THERAPEUTICS, INC.
|
TENX
|
Unlock Forecast
|
$25M
|
-14.9x
|
0.2x
|
Terns Pharmaceuticals, Inc.
|
TERN
|
Unlock Forecast
|
$634M
|
-5.1x
|
2.1x
|
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
TEVA
|
Unlock Forecast
|
$21179M
|
-13.9x
|
3.1x
|
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
TEVJF
|
Unlock Forecast
|
$16614M
|
x
|
2.4x
|
TFF Pharmaceuticals, Inc.
|
TFFP
|
Unlock Forecast
|
$0M
|
0.0x
|
0.1x
|
TG THERAPEUTICS, INC.
|
TGTX
|
Unlock Forecast
|
$4696M
|
77.7x
|
17.0x
|
Tharimmune, Inc.
|
THAR
|
Unlock Forecast
|
$4M
|
-0.6x
|
-5.4x
|
Third Harmonic Bio, Inc.
|
THRD
|
Unlock Forecast
|
$242M
|
9.6x
|
0.9x
|
TALPHERA, INC.
|
TLPH
|
Unlock Forecast
|
$8M
|
-2.3x
|
1.5x
|
Tango Therapeutics, Inc.
|
TNGX
|
Unlock Forecast
|
$765M
|
-2.8x
|
5.7x
|
Tonix Pharmaceuticals Holding Corp.
|
TNXP
|
Unlock Forecast
|
$270M
|
0.0x
|
1.6x
|
Theriva Biologics, Inc.
|
TOVX
|
Unlock Forecast
|
$4M
|
-0.4x
|
0.1x
|
Tempest Therapeutics, Inc.
|
TPST
|
Unlock Forecast
|
$23M
|
-0.5x
|
2.1x
|
Traws Pharma, Inc.
|
TRAW
|
Unlock Forecast
|
$9M
|
-0.6x
|
1.4x
|
Entrada Therapeutics, Inc.
|
TRDA
|
Unlock Forecast
|
$253M
|
6.9x
|
0.7x
|
Trevi Therapeutics, Inc.
|
TRVI
|
Unlock Forecast
|
$936M
|
-6.1x
|
4.7x
|
2seventy bio, Inc.
|
TSVT
|
Unlock Forecast
|
$266M
|
-1.4x
|
1.2x
|
Tvardi Therapeutics, Inc.
|
TVRD
|
Unlock Forecast
|
$36M
|
x
|
-28.5x
|
Travere Therapeutics, Inc.
|
TVTX
|
Unlock Forecast
|
$1431M
|
-8.0x
|
43.6x
|
TherapeuticsMD, Inc.
|
TXMD
|
Unlock Forecast
|
$13M
|
-2.2x
|
0.5x
|
Tyra Biosciences, Inc.
|
TYRA
|
Unlock Forecast
|
$733M
|
-9.5x
|
2.4x
|
Unity Biotechnology, Inc.
|
UBX
|
Unlock Forecast
|
$2M
|
-0.5x
|
-8.7x
|
Unicycive Therapeutics, Inc.
|
UNCY
|
Unlock Forecast
|
$587M
|
-0.9x
|
52.1x
|
Upstream Bio, Inc.
|
UPB
|
Unlock Forecast
|
$948M
|
x
|
2.3x
|
UroGen Pharma Ltd.
|
URGN
|
Unlock Forecast
|
$878M
|
-2.5x
|
-15.2x
|
UNITED THERAPEUTICS Corp
|
UTHR
|
Unlock Forecast
|
$15143M
|
12.2x
|
2.1x
|
VACCINEX, INC.
|
VCNX
|
Unlock Forecast
|
$3M
|
-0.1x
|
1.4x
|
Vera Therapeutics, Inc.
|
VERA
|
Unlock Forecast
|
$1398M
|
-20.4x
|
3.0x
|
VERU INC.
|
VERU
|
Unlock Forecast
|
$89M
|
-0.8x
|
4.3x
|
Verve Therapeutics, Inc.
|
VERV
|
Unlock Forecast
|
$973M
|
-2.5x
|
2.1x
|
Vincerx Pharma, Inc.
|
VINC
|
Unlock Forecast
|
$0M
|
-0.2x
|
0.1x
|
Viracta Therapeutics, Inc.
|
VIRX
|
Unlock Forecast
|
$1M
|
-0.2x
|
-0.1x
|
Viking Therapeutics, Inc.
|
VKTX
|
Unlock Forecast
|
$3602M
|
-67.5x
|
4.3x
|
Vanda Pharmaceuticals Inc.
|
VNDA
|
Unlock Forecast
|
$281M
|
-16.1x
|
0.6x
|
Verrica Pharmaceuticals Inc.
|
VRCA
|
Unlock Forecast
|
$52M
|
-0.5x
|
-4.1x
|
Viridian Therapeutics, Inc.\DE
|
VRDN
|
Unlock Forecast
|
$1391M
|
-4.5x
|
2.3x
|
Vireo Growth Inc.
|
VREOF
|
Unlock Forecast
|
$329M
|
x
|
1.2x
|
Verona Pharma plc
|
VRNA
|
Unlock Forecast
|
$72618M
|
-185.1x
|
261.0x
|
Virpax Pharmaceuticals, Inc.
|
VRPX
|
Unlock Forecast
|
$0M
|
0.0x
|
-19.5x
|
VERTEX PHARMACEUTICALS INC / MA
|
VRTX
|
Unlock Forecast
|
$102415M
|
28.2x
|
6.0x
|
Verastem, Inc.
|
VSTM
|
Unlock Forecast
|
$284M
|
-6.5x
|
-8.7x
|
Vistagen Therapeutics, Inc.
|
VTGN
|
Unlock Forecast
|
$98M
|
-0.1x
|
1.7x
|
Viatris Inc
|
VTRS
|
Unlock Forecast
|
$0M
|
-29.5x
|
0.0x
|
vTv Therapeutics Inc.
|
VTVT
|
Unlock Forecast
|
$0M
|
-3.3x
|
-7.5x
|
Ventyx Biosciences, Inc.
|
VTYX
|
Unlock Forecast
|
$195M
|
-1.0x
|
0.9x
|
VYNE Therapeutics Inc.
|
VYNE
|
Unlock Forecast
|
$14M
|
-0.4x
|
0.4x
|
Whitehawk Therapeutics, Inc.
|
WHWK
|
Unlock Forecast
|
$96M
|
x
|
0.6x
|
Wave Life Sciences Ltd.
|
WVE
|
Unlock Forecast
|
$1285M
|
-22.2x
|
7.5x
|
Xenetic Biosciences, Inc.
|
XBIO
|
Unlock Forecast
|
$6M
|
-1.4x
|
1.1x
|
XBiotech Inc.
|
XBIT
|
Unlock Forecast
|
$98M
|
-3.5x
|
0.6x
|
EXICURE, INC.
|
XCUR
|
Unlock Forecast
|
$49M
|
-1.9x
|
4.3x
|
Xenon Pharmaceuticals Inc.
|
XENE
|
Unlock Forecast
|
$2424M
|
-15.4x
|
3.4x
|
Xeris Biopharma Holdings, Inc.
|
XERS
|
Unlock Forecast
|
$1249M
|
324.0x
|
-23.8x
|
Xilio Therapeutics, Inc.
|
XLO
|
Unlock Forecast
|
$120M
|
-0.5x
|
17.0x
|
Xencor Inc
|
XNCR
|
Unlock Forecast
|
$638M
|
-8.4x
|
1.0x
|
XOMA Royalty Corp
|
XOMA
|
Unlock Forecast
|
$776M
|
-11.7x
|
10.7x
|
XOMA Royalty Corp
|
XOMAO
|
Unlock Forecast
|
$576M
|
-10.1x
|
8.0x
|
XOMA Royalty Corp
|
XOMAP
|
Unlock Forecast
|
$587M
|
-10.5x
|
8.1x
|
Y-mAbs Therapeutics, Inc.
|
YMAB
|
Unlock Forecast
|
$195M
|
-16.9x
|
2.2x
|
Zenas BioPharma, Inc.
|
ZBIO
|
Unlock Forecast
|
$720M
|
x
|
3.0x
|
Zai Lab Ltd
|
ZLAB
|
Unlock Forecast
|
$38513M
|
-95.2x
|
48.6x
|
Zentalis Pharmaceuticals, Inc.
|
ZNTL
|
Unlock Forecast
|
$101M
|
-1.4x
|
0.3x
|
Zomedica Corp.
|
ZOM
|
Unlock Forecast
|
$122M
|
-2.6x
|
0.6x
|
Zomedica Corp.
|
ZOMDF
|
Unlock Forecast
|
$41M
|
x
|
0.3x
|
Zoetis Inc.
|
ZTS
|
Unlock Forecast
|
$69962M
|
26.8x
|
14.1x
|
ZEVRA THERAPEUTICS, INC.
|
ZVRA
|
Unlock Forecast
|
$660M
|
-55.3x
|
16.1x
|
ZyVersa Therapeutics, Inc.
|
ZVSA
|
Unlock Forecast
|
$1M
|
-0.1x
|
0.1x
|
Zymeworks Inc.
|
ZYME
|
Unlock Forecast
|
$1137M
|
-8.3x
|
3.4x
|